Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05404711 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation
A NA study of PreDiabetes and Insulin Resistance, sponsored by Mary Ellen Vajravelu, MD.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05404711: Completed NA study of PreDiabetes and Insulin Resistance, sponsored by Mary Ellen Vajravelu, MD.
NCT05404711 is a NA study of PreDiabetes and Insulin Resistance that has completed, run by Mary Ellen Vajravelu, MD. The registered enrollment target is 40 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05404711, a NA study of PreDiabetes and Insulin Resistance, has completed, sponsored by Mary Ellen Vajravelu, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine whether continuous glucose monitors (CGM) are a safe, effective, and acceptable way to evaluate type 2 diabetes risk in youth as compared to the standard 2-hour oral glucose tolerance test (OGTT). This study will involve wearing a CGM, wearing a physical activity tracker, responding to surveys, and completing at-home glucose and mixed food challenge while wearing the CGM. Subjects will also be asked to complete an interview by phone or videoconference after wearing the CGM.
Primary Outcome
Completeness of CGM data (≥ 80% of days with data)
Conditions Studied
Interventions
- DEVICE CGM
Study Locations (1)
Pennsylvania
- Children's Hospital of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-10-11 |
| Est. Completion | 2023-12-14 |
| Phase | NA |
What the finished NCT05404711 record still lists
NCT05404711 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (94% lower).
The record links to 3 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which CGM is the first listed.
NCT05404711 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05404711 about?
NCT05404711 is a clinical study titled "Continuous Glucose Monitors (CGM) for Type 2 Diabetes (T2D) Risk Evaluation". The purpose of this research study is to determine whether continuous glucose monitors (CGM) are a safe, effective, and acceptable way to evaluate type 2 diabetes risk in youth as compared to the standard 2-hour oral glucose tolerance test (OGTT). This study will involve wearing a CGM, wearing a ph...
What is the current status of trial NCT05404711?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-10-11. Estimated completion is 2023-12-14.
What conditions does trial NCT05404711 study?
This clinical trial studies the following conditions: PreDiabetes, Insulin Resistance, Overweight and Obesity.
What interventions are being tested in trial NCT05404711?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT05404711?
This trial is sponsored by Mary Ellen Vajravelu, MD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05404711 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05404711's enrollment target sits among peer trials
40 108th of 149 higher than 37 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI